iTeos Therapeutics, Inc. Insider Transactions
Purchase
Sell
iTeos Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Hallal David
Director |
Sell | 38,228 @ $10.24 | $391.46 K | 0 | 06/06/2025 | 06/06/2025 | |
|
Detheux Michel
CEO |
Sell | 43,882 @ $10.21 | $448.04 K | 0 | 06/06/2025 | 06/06/2025 | |
|
Detheux Michel
CEO |
Sell | 8,400 @ $10.21 | $85.76 K | 135,903 | 06/06/2025 | 06/06/2025 | |
|
Detheux Michel
CEO |
Sell | 43,882 @ $10.15 | $445.40 K | 0 | 06/05/2025 | 06/06/2025 | |
|
Hallal David
Director |
Sell | 38,227 @ $10.15 | $388.00 K | 0 | 06/05/2025 | 06/06/2025 | |
|
Detheux Michel
CEO |
Sell | 8,400 @ $10.15 | $85.26 K | 135,903 | 06/05/2025 | 06/06/2025 | |
|
Hallal David
Director |
Sell | 38,227 @ $10.07 | $384.95 K | 0 | 06/04/2025 | 06/06/2025 | |
|
Detheux Michel
CEO |
Sell | 43,883 @ $10.10 | $443.22 K | 0 | 06/04/2025 | 06/06/2025 | |
|
Detheux Michel
CEO |
Sell | 8,400 @ $10.10 | $84.84 K | 135,903 | 06/04/2025 | 06/06/2025 | |
|
EcoR1 Capital, LLC
10 percent owner |
Buy | 3,300,000 @ $8.00 | $26.40 M | 10,688,978 | 05/15/2025 | 05/16/2025 | |
|
EcoR1 Capital, LLC
10 percent owner |
Buy | 1,658,978 @ $7.41 | $12.29 M | 7,388,978 | 05/14/2025 | 05/16/2025 | |
|
GADICKE ANSBERT
Other: Former 10% Owner |
Sell | 1,031,931 @ $8.06 | $8.32 M | 3,452,797 | 05/13/2025 | 05/15/2025 | |
|
MPM BIOVENTURES 2018, L.P.
Other: Former 10% Owner |
Sell | 630,191 @ $8.06 | $5.08 M | 2,108,594 | 05/13/2025 | 05/15/2025 | |
|
MPM BioVentures 2014, L.P.
Other: Former 10% Owner |
Sell | 630,191 @ $8.06 | $5.08 M | 2,108,594 | 05/13/2025 | 05/15/2025 | |
|
Gall Matthew
CFO |
Buy | 5,000 @ $7.73 | $38.64 K | 65,429 | 11/19/2024 | 11/19/2024 | |
|
RA CAPITAL MANAGEMENT, L.P.
Other: Former 10% Owner |
Buy | 5,714,285 @ $0.00 | $5.71 K | 5,714,285 | 05/10/2024 | 05/14/2024 | |
|
Gall Matthew
CFO |
Buy | 5,000 @ $8.37 | $41.85 K | 19,429 | 10/12/2023 | 10/12/2023 | |
| Sell | 34,846 @ $14.19 | $494.47 K | 2,119,212 | 08/23/2023 | 08/25/2023 | ||
| Sell | 95,516 @ $15.63 | $1.49 M | 2,023,696 | 08/23/2023 | 08/25/2023 | ||
| Sell | 219,638 @ $16.87 | $3.71 M | 1,804,058 | 08/23/2023 | 08/25/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
iTeos Therapeutics, Inc. FAQ's
The list of insiders at iTeos Therapeutics, Inc. includes Gall Matthew, GADICKE ANSBERT, MPM BIOVENTURES 2018, L.P., MPM BioVentures 2014, L.P., EcoR1 Capital, LLC, Detheux Michel, Hallal David.
Insiders have sold a total of 2.56 M iTeos Therapeutics, Inc. shares in the last 12 months for a total of 21.23 M sold.
The following insiders have sold iTeos Therapeutics, Inc. shares in the last 12 months: GADICKE ANSBERT ($8.32 M), MPM BIOVENTURES 2018, L.P. ($5.08 M), MPM BioVentures 2014, L.P. ($5.08 M), Detheux Michel ($1.59 M), Hallal David ($1.16 M),
Insiders have purchased a total of 4.96 M iTeos Therapeutics, Inc. shares in the last 12 months for a total of 38.72 M.
The following insiders have purchased iTeos Therapeutics, Inc. shares in the last 12 months: Gall Matthew ($38.64 K), EcoR1 Capital, LLC ($38.69 M),